Company intelligence / Profile preview

Apostle

Pleasanton, California, United Statesapostlebio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Apostle's technologies have demonstrated higher yields of cell-free DNA compared to leading competitors in independent studies. Their products are widely used in research and clinical settings for liquid biopsy applications such as early cancer detection and NIPT. The company has received CLIA accreditation for its diagnostic labs and a California Medical Device Manufacturing License. Strategic partnerships include an exclusive agreement with Beckman Coulter Life Sciences.

Therapeutic areas: OncologyInfectious DiseasesWomen's Health
Modalities: Device (cfDNA extraction kits)Diagnostic assay (liquid biopsy)Nanochemistry-based technologyBioinformatics platform
Industry: Molecular Diagnostics

Partnerships

Beckman Coulter Life Sciences (exclusive agreement)Haier Biomedical distribution partnership

Beyond the preview

Go deeper on Apostle.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apostle.

Explore the full profile